VRPX Stock: What Investors Are Saying About Virpax Pharma as Shares Continue to Fly

Investors continue to drive Virpax Pharmaceuticals (NASDAQ:VRPX) stock higher on Wednesday after Tuesday’s major company news emerged.

A scientist holding up her biotech experiment in a small Petri dish.

Source: Shutterstock

The Pennsylvania-based firm said yesterday that it received a written response from the U.S. Food and Drug Administration (FDA) concerning its MMS019 anti-viral barrier product. According to InvestorPlace writer William White, the “response from the FDA is for the company’s pre-investigational new drug and opens the way for Virpax Pharma to submit a New Drug Application (NDA) for MMS019.”

In turn, the NDA could be used as a daily treatment against the “inhibition of viral replication of SARS-CoV-2 and influenza in animals.” And according to the release, Virpax Pharma is considering submitting its NDA to the Office of Non-Prescription Drugs.

With all of this in mind, what are investors saying about VRPX stock? Let’s take a closer look to find out.

VRPX (compliments of u/wilsash42) a 260% green day. Pharma play on great pharma news. Maybe our next NAOV? Don’t jump in now! Looking for comedown tomorrow to be oversold and possible entries. MAY STILL TOTALLY RUN THOUGH! from RDTS

If you’re looking for more updates from Wall Street, InvestorPlace has all the latest stock market news you need to know. This includes the latest on PharmaCyte Biotech (NASDAQ:PMCB), Dogecoin (CCC:DOGE-USD) and Palantir (NYSE:PLTR) on Wednesday. You can find all of this info at the links below!

More Wednesday Stock Market News

On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Nick Clarkson is a web editor at InvestorPlace.

Article printed from InvestorPlace Media, https://investorplace.com/2021/08/vrpx-stock-what-investors-are-saying-about-virpax-pharma-as-shares-continue-to-fly/.

©2023 InvestorPlace Media, LLC